Do CYP2C19 and ABCB1 gene polymorphisms and low CYP3A4 isoenzyme activity have an impact on stent implantation complications in acute coronary syndrome patients?

Eric Rytkin1 Russian Medical Academy of Continuous Professional EducationCorrespondence[email protected]

Karin B Mirzaev1 Russian Medical Academy of Continuous Professional Education

Elena A Grishina1 Russian Medical Academy of Continuous Professional Education

Valeriy V Smirnov2 I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russian Federation

Kristina A Ryzhikova1 Russian Medical Academy of Continuous Professional Education

Zhannet A Sozaeva1 Russian Medical Academy of Continuous Professional Education

Michael Iu Giliarov2 I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russian Federation

Denis A Andreev2 I.M. Sechenov First Moscow State Medical University, Ministry of Health of the Russian Federation, Moscow, Russian Federation

Dmitriy A Sychev1 Russian Medical Academy of Continuous Professional Education

References

LevineGNBatesERBittlJA2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery diseaseJ Am Coll Cardiol201668101082111527036918
PubMed Web of Science ®Google Scholar
GiustiBGoriAMMarcucciRSaraciniCVestriniAAbbateRDeterminants to optimize response to clopidogrel in acute coronary syndromePharmgenomics Pers Med20103335023226041
PubMedGoogle Scholar
GiustiBGoriAMMarcucciRAbbateRRelation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosisExpert Opin Drug Metab Toxicol20106439340720163283
PubMed Web of Science ®Google Scholar
PanicciaRAntonucciEGoriAMDifferent methodologies for evaluating the effect of clopidogrel on platelet function in high-risk coronary artery disease patientsJ Thromb Haemost2007591839184717723123
PubMed Web of Science ®Google Scholar
ZhestovskajaASKukesVGSychevDAPersonalized medicine: myth or reality? The position of Russian clinical pharmacologistsEPMA J2013411323663439
PubMedGoogle Scholar
GedCRouillonJMPichardLThe increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA inductionBr J Clin Pharmacol19892843733872590599
PubMed Web of Science ®Google Scholar
MicudaSHodacMSisperaLInfluence of amiodarone on urinary excretion of 6 beta-hydroxycortisol in humansPhysiol Res200150219119611522047
PubMed Web of Science ®Google Scholar